Andersen L, Williams M, Pease S, Dhatt H, Delong P
Ther Innov Regul Sci. 2025; .
PMID: 40056370
DOI: 10.1007/s43441-025-00767-1.
Takeyama S, Hanaoka H, Hashimoto A, Ishii Y, Shimizu Y, Takeuchi T
BMC Rheumatol. 2025; 9(1):25.
PMID: 40012072
PMC: 11863849.
DOI: 10.1186/s41927-025-00474-2.
Gyawali B, Roto D, Lachant M, White R, Lachant D
Pulm Circ. 2025; 15(1):e70048.
PMID: 39925946
PMC: 11806521.
DOI: 10.1002/pul2.70048.
Varga A, Cristescu L, Iancu D, Dumbrava R, Moldovan D, Stoica F
J Clin Med. 2024; 13(22).
PMID: 39597925
PMC: 11595160.
DOI: 10.3390/jcm13226782.
Ford H, Brunetti C, Ferrari P, Meszaros G, Moles V, Skaara H
Eur Respir J. 2024; 64(4).
PMID: 39209479
PMC: 11525333.
DOI: 10.1183/13993003.01129-2024.
Clinical trial design, end-points, and emerging therapies in pulmonary arterial hypertension.
Weatherald J, Fleming T, Wilkins M, Cascino T, Psotka M, Zamanian R
Eur Respir J. 2024; 64(4).
PMID: 39209468
PMC: 11525337.
DOI: 10.1183/13993003.01205-2024.
Association of risk assessment at diagnosis with healthcare resource utilization and health-related quality of life outcomes in pulmonary arterial hypertension.
Lawrie A, Hamilton N, Wood S, Exposto F, Muzwidzwa R, Raiteri L
Pulm Circ. 2024; 14(3):e12399.
PMID: 38979095
PMC: 11229026.
DOI: 10.1002/pul2.12399.
A PrOsPective Cohort Study on Interstitial Lung Disease-Associated Pulmonary Hypertension with a ParticulaR Focus on the Subset with Pulmonary Arterial Hypertension Features (POPLAR Study).
Tsujino I, Kitahara K, Omura J, Iwahori T, Konno S
Pulm Ther. 2024; 10(3):297-313.
PMID: 38913242
PMC: 11339191.
DOI: 10.1007/s41030-024-00264-0.
Exploratory and confirmatory factor analysis of emPHasis-10: The health-related quality-of-life measure in pulmonary hypertension.
Rawlings G, Gaskell C, Beail N, Thompson A, Armstrong I
Pulm Circ. 2024; 14(2):e12378.
PMID: 38736895
PMC: 11088805.
DOI: 10.1002/pul2.12378.
Sildenafil Versus Placebo for Early Pulmonary Vascular Disease in Scleroderma (SEPVADIS): protocol for a randomized controlled trial.
Lammi M, Mukherjee M, Saketkoo L, Carey K, Hummers L, Hsu S
BMC Pulm Med. 2024; 24(1):211.
PMID: 38689245
PMC: 11061972.
DOI: 10.1186/s12890-024-02892-3.
Assessing the clinical benefit, safety, and patient-reported outcomes with the use of the PAHcare™ digital platform in pulmonary arterial hypertension: a pilot study.
Penate G, Ochoa Parra N, Morera J, Martinez Menaca A, Lopez Ramon M, Menendez S
Front Public Health. 2024; 12:1335072.
PMID: 38435295
PMC: 10904626.
DOI: 10.3389/fpubh.2024.1335072.
Health-Related Quality of Life Across the Spectrum of Pulmonary Hypertension.
Balasubramanian A, Brett Larive A, Horn E, DuBrock H, Mehra R, Jacob M
Chest. 2024; 165(6):1493-1504.
PMID: 38354903
PMC: 11177102.
DOI: 10.1016/j.chest.2024.02.009.
Risk assessment and real-world outcomes in chronic thromboembolic pulmonary hypertension: insights from a UK pulmonary hypertension referral service.
Kiely D, Hamilton N, Wood S, Durrington C, Exposto F, Muzwidzwa R
BMJ Open. 2024; 14(1):e080068.
PMID: 38176861
PMC: 10773408.
DOI: 10.1136/bmjopen-2023-080068.
Peak steps: Capacity for activity improves after adding approved therapy in pulmonary arterial hypertension.
Lachant D, Light A, Lachant M, Annis J, Hemnes A, Brittain E
Pulm Circ. 2023; 13(3):e12285.
PMID: 37701142
PMC: 10493080.
DOI: 10.1002/pul2.12285.
Implementing the EXPEDITE parenteral induction protocol: Rapid parenteral treprostinil titration and transition to oral treprostinil.
Kingrey J, Miller C, Franco V, Smith J, Zolty R, Oudiz R
Pulm Circ. 2023; 13(3):e12255.
PMID: 37497167
PMC: 10368085.
DOI: 10.1002/pul2.12255.
Right ventricular functional recovery assessment with stress echocardiography and cardiopulmonary exercise testing after pulmonary embolism: a pilot prospective multicentre study.
Samaranayake C, Upham J, Tran K, Howard L, Nguyen S, Lwin M
BMJ Open Respir Res. 2023; 10(1).
PMID: 37491130
PMC: 10373684.
DOI: 10.1136/bmjresp-2023-001637.
Establishing minimally important differences for cardiac MRI end-points in pulmonary arterial hypertension.
Alabed S, Garg P, Alandejani F, Dwivedi K, Maiter A, Karunasaagarar K
Eur Respir J. 2023; 62(2).
PMID: 37414419
PMC: 10397469.
DOI: 10.1183/13993003.02225-2022.
Patient perspectives on pulmonary hypertension in the United States: Burdens, expectations, and goals.
Braley K, Richardson K, Whitley L, Werner K, Appleby L
Pulm Circ. 2023; 13(2):e12247.
PMID: 37346966
PMC: 10279947.
DOI: 10.1002/pul2.12247.
"It's that invisible illness": Patient and clinician perspectives on outcomes in pulmonary arterial hypertension treatment.
Auriemma C, Minhas J, Blue R, Lapatra T, Kawut S, Courtright K
Pulm Circ. 2023; 13(2):e12236.
PMID: 37180826
PMC: 10166884.
DOI: 10.1002/pul2.12236.
Can self-compassion help us better understand the impact of pulmonary hypertension on those with the condition and their carers? A cross-sectional analysis.
Rawlings G, Novakova B, Armstrong I, Thompson A
Pulm Circ. 2023; 13(1):e12208.
PMID: 36937150
PMC: 10016088.
DOI: 10.1002/pul2.12208.